[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Recombinant Antihemophilic Factor Market Report 2018

March 2018 | 100 pages | ID: U6AE1E8AC79EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Recombinant Antihemophilic Factor market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Recombinant Antihemophilic Factor in these regions, from 2013 to 2025 (forecast).
United States Recombinant Antihemophilic Factor market competition by top manufacturers/players, with Recombinant Antihemophilic Factor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Biogen
  • Octapharma
  • NovoNordisk
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • 200IU
  • 250IU
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Pharmacy
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Recombinant Antihemophilic Factor Market Report 2018

1 RECOMBINANT ANTIHEMOPHILIC FACTOR OVERVIEW

1.1 Product Overview and Scope of Recombinant Antihemophilic Factor
1.2 Classification of Recombinant Antihemophilic Factor by Product Category
  1.2.1 United States Recombinant Antihemophilic Factor Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Recombinant Antihemophilic Factor Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 200IU
  1.2.4 250IU
1.3 United States Recombinant Antihemophilic Factor Market by Application/End Users
  1.3.1 United States Recombinant Antihemophilic Factor Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 United States Recombinant Antihemophilic Factor Market by Region
  1.4.1 United States Recombinant Antihemophilic Factor Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Recombinant Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.3 Southwest Recombinant Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Recombinant Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.5 New England Recombinant Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.6 The South Recombinant Antihemophilic Factor Status and Prospect (2013-2025)
  1.4.7 The Midwest Recombinant Antihemophilic Factor Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Recombinant Antihemophilic Factor (2013-2025)
  1.5.1 United States Recombinant Antihemophilic Factor Sales and Growth Rate (2013-2025)
  1.5.2 United States Recombinant Antihemophilic Factor Revenue and Growth Rate (2013-2025)

2 UNITED STATES RECOMBINANT ANTIHEMOPHILIC FACTOR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Recombinant Antihemophilic Factor Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Recombinant Antihemophilic Factor Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Recombinant Antihemophilic Factor Average Price by Players/Suppliers (2013-2018)
2.4 United States Recombinant Antihemophilic Factor Market Competitive Situation and Trends
  2.4.1 United States Recombinant Antihemophilic Factor Market Concentration Rate
  2.4.2 United States Recombinant Antihemophilic Factor Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Recombinant Antihemophilic Factor Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RECOMBINANT ANTIHEMOPHILIC FACTOR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Recombinant Antihemophilic Factor Sales and Market Share by Region (2013-2018)
3.2 United States Recombinant Antihemophilic Factor Revenue and Market Share by Region (2013-2018)
3.3 United States Recombinant Antihemophilic Factor Price by Region (2013-2018)

4 UNITED STATES RECOMBINANT ANTIHEMOPHILIC FACTOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Recombinant Antihemophilic Factor Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Recombinant Antihemophilic Factor Revenue and Market Share by Type (2013-2018)
4.3 United States Recombinant Antihemophilic Factor Price by Type (2013-2018)
4.4 United States Recombinant Antihemophilic Factor Sales Growth Rate by Type (2013-2018)

5 UNITED STATES RECOMBINANT ANTIHEMOPHILIC FACTOR SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Recombinant Antihemophilic Factor Sales and Market Share by Application (2013-2018)
5.2 United States Recombinant Antihemophilic Factor Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES RECOMBINANT ANTIHEMOPHILIC FACTOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Shire (Baxter)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Antihemophilic Factor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shire (Baxter) Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Recombinant Antihemophilic Factor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CSL
  6.3.2 Recombinant Antihemophilic Factor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Recombinant Antihemophilic Factor Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biogen
  6.5.2 Recombinant Antihemophilic Factor Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biogen Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Octapharma
  6.6.2 Recombinant Antihemophilic Factor Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Octapharma Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 NovoNordisk
  6.7.2 Recombinant Antihemophilic Factor Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 NovoNordisk Recombinant Antihemophilic Factor Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview

7 RECOMBINANT ANTIHEMOPHILIC FACTOR MANUFACTURING COST ANALYSIS

7.1 Recombinant Antihemophilic Factor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Antihemophilic Factor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Antihemophilic Factor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Antihemophilic Factor Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RECOMBINANT ANTIHEMOPHILIC FACTOR MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Recombinant Antihemophilic Factor Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Recombinant Antihemophilic Factor Sales Volume Forecast by Type (2018-2025)
11.3 United States Recombinant Antihemophilic Factor Sales Volume Forecast by Application (2018-2025)
11.4 United States Recombinant Antihemophilic Factor Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Recombinant Antihemophilic Factor
Figure United States Recombinant Antihemophilic Factor Market Size (K Units) by Type (2013-2025)
Figure United States Recombinant Antihemophilic Factor Sales Volume Market Share by Type (Product Category) in 2017
Figure 200IU Product Picture
Figure 250IU Product Picture
Figure United States Recombinant Antihemophilic Factor Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Recombinant Antihemophilic Factor by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure United States Recombinant Antihemophilic Factor Market Size (Million USD) by Region (2013-2025)
Figure The West Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Recombinant Antihemophilic Factor Sales (K Units) and Growth Rate (2013-2025)
Figure United States Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Recombinant Antihemophilic Factor Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Recombinant Antihemophilic Factor Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Recombinant Antihemophilic Factor Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Recombinant Antihemophilic Factor Sales Share by Players/Suppliers
Figure 2017 United States Recombinant Antihemophilic Factor Sales Share by Players/Suppliers
Figure United States Recombinant Antihemophilic Factor Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Recombinant Antihemophilic Factor Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Recombinant Antihemophilic Factor Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Recombinant Antihemophilic Factor Revenue Share by Players/Suppliers
Figure 2017 United States Recombinant Antihemophilic Factor Revenue Share by Players/Suppliers
Table United States Market Recombinant Antihemophilic Factor Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Recombinant Antihemophilic Factor Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Recombinant Antihemophilic Factor Market Share of Top 3 Players/Suppliers
Figure United States Recombinant Antihemophilic Factor Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Recombinant Antihemophilic Factor Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Recombinant Antihemophilic Factor Product Category
Table United States Recombinant Antihemophilic Factor Sales (K Units) by Region (2013-2018)
Table United States Recombinant Antihemophilic Factor Sales Share by Region (2013-2018)
Figure United States Recombinant Antihemophilic Factor Sales Share by Region (2013-2018)
Figure United States Recombinant Antihemophilic Factor Sales Market Share by Region in 2017
Table United States Recombinant Antihemophilic Factor Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Recombinant Antihemophilic Factor Revenue Share by Region (2013-2018)
Figure United States Recombinant Antihemophilic Factor Revenue Market Share by Region (2013-2018)
Figure United States Recombinant Antihemophilic Factor Revenue Market Share by Region in 2017
Table United States Recombinant Antihemophilic Factor Price (USD/Unit) by Region (2013-2018)
Table United States Recombinant Antihemophilic Factor Sales (K Units) by Type (2013-2018)
Table United States Recombinant Antihemophilic Factor Sales Share by Type (2013-2018)
Figure United States Recombinant Antihemophilic Factor Sales Share by Type (2013-2018)
Figure United States Recombinant Antihemophilic Factor Sales Market Share by Type in 2017
Table United States Recombinant Antihemophilic Factor Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Recombinant Antihemophilic Factor Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Recombinant Antihemophilic Factor by Type (2013-2018)
Figure Revenue Market Share of Recombinant Antihemophilic Factor by Type in 2017
Table United States Recombinant Antihemophilic Factor Price (USD/Unit) by Types (2013-2018)
Figure United States Recombinant Antihemophilic Factor Sales Growth Rate by Type (2013-2018)
Table United States Recombinant Antihemophilic Factor Sales (K Units) by Application (2013-2018)
Table United States Recombinant Antihemophilic Factor Sales Market Share by Application (2013-2018)
Figure United States Recombinant Antihemophilic Factor Sales Market Share by Application (2013-2018)
Figure United States Recombinant Antihemophilic Factor Sales Market Share by Application in 2017
Table United States Recombinant Antihemophilic Factor Sales Growth Rate by Application (2013-2018)
Figure United States Recombinant Antihemophilic Factor Sales Growth Rate by Application (2013-2018)
Table Shire (Baxter) Basic Information List
Table Shire (Baxter) Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire (Baxter) Recombinant Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Shire (Baxter) Recombinant Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Shire (Baxter) Recombinant Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Recombinant Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Bayer Recombinant Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Bayer Recombinant Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table CSL Basic Information List
Table CSL Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Recombinant Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure CSL Recombinant Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure CSL Recombinant Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Recombinant Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Pfizer Recombinant Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Pfizer Recombinant Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Biogen Basic Information List
Table Biogen Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biogen Recombinant Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Biogen Recombinant Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Biogen Recombinant Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Octapharma Basic Information List
Table Octapharma Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Octapharma Recombinant Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure Octapharma Recombinant Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure Octapharma Recombinant Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table NovoNordisk Basic Information List
Table NovoNordisk Recombinant Antihemophilic Factor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure NovoNordisk Recombinant Antihemophilic Factor Sales Growth Rate (2013-2018)
Figure NovoNordisk Recombinant Antihemophilic Factor Sales Market Share in United States (2013-2018)
Figure NovoNordisk Recombinant Antihemophilic Factor Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antihemophilic Factor
Figure Manufacturing Process Analysis of Recombinant Antihemophilic Factor
Figure Recombinant Antihemophilic Factor Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antihemophilic Factor Major Players/Suppliers in 2017
Table Major Buyers of Recombinant Antihemophilic Factor
Table Distributors/Traders List
Figure United States Recombinant Antihemophilic Factor Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Recombinant Antihemophilic Factor Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Recombinant Antihemophilic Factor Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Recombinant Antihemophilic Factor Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Recombinant Antihemophilic Factor Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Recombinant Antihemophilic Factor Sales Volume (K Units) Forecast by Type in 2025
Table United States Recombinant Antihemophilic Factor Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Recombinant Antihemophilic Factor Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Recombinant Antihemophilic Factor Sales Volume (K Units) Forecast by Application in 2025
Table United States Recombinant Antihemophilic Factor Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Recombinant Antihemophilic Factor Sales Volume Share Forecast by Region (2018-2025)
Figure United States Recombinant Antihemophilic Factor Sales Volume Share Forecast by Region (2018-2025)
Figure United States Recombinant Antihemophilic Factor Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories